Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Wave Life Sciences Ltd (WVE)

229 + Investors. Track Smart Money conviction in WVE. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +13
Streak
3Q ▲
Buyers last Q
64%

Smart Money Signals — WVE

Based on 231 hedge funds · latest filing: 2026 Q1 · updated quarterly

📈

Buying streak — 3 quarters in a row

last 6Q
For 3 consecutive quarters, more hedge funds added WVE than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
🏔️

At the ownership peak (100% of max)

100% of all-time peak
231 hedge funds hold WVE right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
📶

Steady growth — +19% more funds vs a year ago

fund count last 6Q
+37 new funds entered over the past year (+19% YoY). Gradual, steady growth in institutional ownership is generally a healthy signal — not a speculative rush, but consistent conviction.
🟢

More buyers than sellers — 64% buying

161 buying90 selling
Last quarter: 161 funds were net buyers (50 opened a brand new position + 111 added to an existing one). Only 90 were sellers (53 trimmed + 37 sold completely). A clear majority buying is a strong confirmation signal.
⚠️

Fewer new buyers each quarter (-20 vs last Q)

new funds entering per quarter
Funds opening this position for the first time: 24 → 31 → 70 → 50. Each quarter fewer new institutions are entering. This usually means most funds that wanted in are already in — the stock is well-known but the pool of potential new buyers is shrinking.
🔒

45% of holders stayed for 2+ years

■ 45% conviction (2yr+) ■ 25% medium ■ 29% new
105 out of 231 hedge funds have held WVE for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
💎

Buying through price weakness — shares -6%, value -99%

Value
-98%
Shares
-5%
Last quarter: funds added -6% more shares while total portfolio value only changed -99%. Institutions were buying while the price was falling — a high-conviction accumulation signal. They're deliberately loading up on the dip.
🚀

Acceleration phase — new buyers rushing in

35 → 24 → 31 → 70 → 50 new funds/Q
New funds entering each quarter: 24 → 31 → 70 → 50. The pace of institutional discovery is accelerating sharply. This is the 'hot idea' phase — the thesis is being passed from fund to fund. You are not late — the accumulation wave is still building.
🏛️

Deep conviction — 54% of holders stayed 2+ years

■ 54% veterans ■ 14% 1-2yr ■ 32% new
Of 251 current holders: 136 (54%) have held for over 2 years without selling. These are not momentum buyers — they have lived through drawdowns and stayed. A large veteran base acts as a stabilizing force during selloffs.
✅

Strong quality — 21% AUM from major funds

21% from top-100 AUM funds
47 of 231 holders rank in the top 100 by AUM, accounting for 21% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.
4.1
out of 10
Moderate Exit Risk
Exit risk score 4.1/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — WVE

In 2026 Q1, 161 hedge funds were net buyers of WVE (50 opened a new position, 111 added to an existing one), while 90 reduced or exited (53 trimmed, 37 sold completely) — a 64% buyer ratio, indicating clear institutional accumulation. This marks 3 consecutive quarters of net institutional buying — a persistent conviction signal. 21% of total institutional value in WVE is held by top-100 AUM funds, reflecting strong institutional quality. Net fund flow last quarter: +13 funds (more new holders than closures). Total institutional holders: 231.

Hedge Fund Ownership: WVE

How many hedge funds hold WVE — quarterly history vs. share price
Quarterly hedge fund ownership of WVE vs. share price

Market Analysis: WVE

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: WVE

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Wave Life Sciences Ltd (WVE) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much WVE has moved relative to its sector benchmark (XLV) since the 2026 Q1 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End March 31, 2026 · 77d ago
WVE
-17.2%
XLV
nan%

WVE outperformed XLV by nan% since March 31, 2026.

Since 13F Filing Date May 15, 2026 · 32d ago
WVE
-11.4%
XLV
nan%

Since the filing became public, WVE outperformed XLV by nan% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

25 top-rated funds 4 high-conviction
Consensus
6.1
/ 10
breadth
×
Elite
3.0
/ 10
conviction
Hedge Fund Positioning: WVE
229 + Investors

Track Smart Money conviction in WVE. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 229 218 5.05%
13F Shares 177M 188M -5.81%
Total Value $1.20B $99.27B -98.79%
New Positions 49 70 -21
Increased Positions 105 80 +25
Closed Positions 38 42 -4
Reduced Positions 48 48 -
Total Calls 14 13 7.69%
Total Puts 9 9 -
PUT/CALL Ratio 0.64 0.69 Bullish

Statistics: WVE

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

229 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in WVE. Verified SEC 13F-HR filings.

QUARTER:
Top 25 WVE holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 M28 Capital Management LP 61.83% 4,588,284 $33.3M
2 GSK plc 22.08% 18,245,691 $132.3M
3 SymBiosis Capital Partners, LLC 10.30% 750,000 $5.4M
4 Pfizer Inc 5.00% 1,875,000 $11.9M
5 Ra Capital Management, L.P. 2.07% 26,975,505 $195.6M
6 683 Capital Management, LLC 1.85% 4,900,000 $35.5M
7 Scientech Research LLC 1.21% 200,331 $1.5M
8 First Light Asset Management, LLC 1.20% 1,843,968 $13.4M
9 Capstone Capital Management Ltd 1.05% 144,029 $1.0M
10 Maverick Capital Ltd 0.85% 10,161,399 $73.7M
11 Sphera Funds Management LTD. 0.63% 548,272 $4.0M
12 Affinity Asset Advisors, LLC 0.52% 1,401,727 $10.2M
13 Platinum Investment Management Ltd 0.50% 275,269 $2.0M
14 Siren, L.L.C. 0.49% 2,450,000 $17.8M
15 Kynam Capital Management, LP 0.43% 965,193 $7.0M
16 Elmind Capital, LP 0.37% 177,846 $1.3M
17 Privium Fund Management B.V. 0.36% 241,010 $1.7M
18 Moody Aldrich Partners LLC 0.36% 272,533 $2.0M
19 Driehaus Capital Management LLC 0.29% 5,431,021 $39.4M
20 Emerald Advisers, LLC 0.29% 1,261,183 $9.1M
21 Emerald Mutual Fund Advisers Trust 0.29% 814,529 $5.9M
22 Caitong International Asset Management Co., Ltd 0.24% 180,980 $1.3M
23 Newtyn Management, LLC 0.23% 300,000 $2.2M
24 Tang Capital Management LLC 0.22% 600,000 $4.3M
25 AlphaCentric Advisors LLC 0.21% 29,175 $212K
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Wave Life Sciences Ltd (WVE)

What does the Smart Money Trend signal show for WVE?

Buying streak — 3 quarters in a row: For 3 consecutive quarters, more hedge funds added WVE than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for WVE?

More buyers than sellers — 64% buying: Last quarter: 161 funds were net buyers (50 opened a brand new position + 111 added to an existing one). Only 90 were sellers (53 trimmed + 37 sold completely). A clear majority buying is a strong confirmation signal.

What is the fund quality score for WVE holders?

Strong quality — 21% AUM from major funds: 47 of 231 holders rank in the top 100 by AUM, accounting for 21% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

How long have hedge funds held WVE?

45% of holders stayed for 2+ years: 105 out of 231 hedge funds have held WVE for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Is it too late to buy Wave Life Sciences Ltd (WVE) following the 2026 Q1 hedge fund 13F filings?

As of today, WVE has moved -11.4% since the 2026 Q1 13F filing date (May 15, 2026), compared to nan% for the XLV sector ETF — an outperformance of nan%. Since the quarter end (March 31, 2026), WVE has gained -17.2% vs nan% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →